ATE268607T1 - Allergenformulierung - Google Patents

Allergenformulierung

Info

Publication number
ATE268607T1
ATE268607T1 AT98919258T AT98919258T ATE268607T1 AT E268607 T1 ATE268607 T1 AT E268607T1 AT 98919258 T AT98919258 T AT 98919258T AT 98919258 T AT98919258 T AT 98919258T AT E268607 T1 ATE268607 T1 AT E268607T1
Authority
AT
Austria
Prior art keywords
allergen formulation
allergen
formulation
Prior art date
Application number
AT98919258T
Other languages
English (en)
Inventor
Jorj Terry Ulrich
Alan Worland Wheeler
Original Assignee
Allergy Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergy Therapeutics Ltd filed Critical Allergy Therapeutics Ltd
Application granted granted Critical
Publication of ATE268607T1 publication Critical patent/ATE268607T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98919258T 1997-04-05 1998-04-03 Allergenformulierung ATE268607T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9706957.9A GB9706957D0 (en) 1997-04-05 1997-04-05 Formulation
PCT/EP1998/002138 WO1998044947A1 (en) 1997-04-05 1998-04-03 Allergen formulation

Publications (1)

Publication Number Publication Date
ATE268607T1 true ATE268607T1 (de) 2004-06-15

Family

ID=10810358

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98919258T ATE268607T1 (de) 1997-04-05 1998-04-03 Allergenformulierung

Country Status (17)

Country Link
US (2) US7718178B2 (de)
EP (1) EP0975364B1 (de)
JP (1) JP4331798B2 (de)
KR (1) KR100549557B1 (de)
AR (1) AR011707A1 (de)
AT (1) ATE268607T1 (de)
AU (1) AU729631B2 (de)
CA (1) CA2285928C (de)
CO (1) CO4940482A1 (de)
DE (1) DE69824405T2 (de)
ES (1) ES2218819T3 (de)
GB (1) GB9706957D0 (de)
NZ (1) NZ337580A (de)
PT (1) PT975364E (de)
TW (1) TWI240628B (de)
WO (1) WO1998044947A1 (de)
ZA (1) ZA982851B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9706957D0 (en) * 1997-04-05 1997-05-21 Smithkline Beecham Plc Formulation
GB9820525D0 (en) 1998-09-21 1998-11-11 Allergy Therapeutics Ltd Formulation
GB0000891D0 (en) 2000-01-14 2000-03-08 Allergy Therapeutics Ltd Formulation
GB201106802D0 (en) * 2011-04-21 2011-06-01 Allergy Therapeutics Ltd Process for preparing vaccine composition
CN116199727B (zh) * 2021-12-01 2025-04-08 上海安奕康生物科技有限公司 一种mpl三乙胺盐、其制备工艺及应用

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1128637A (en) 1966-09-13 1968-09-25 Beecham Group Ltd Influenza vaccine
US3541201A (en) * 1968-12-18 1970-11-17 Ethan Alan Brown Novel sodium chloride encapsulated injectionable substances
GB1377074A (en) * 1971-07-13 1974-12-11 Beecham Group Ltd Process for preparing injectable compositions
GB1492973A (en) * 1974-02-16 1977-11-23 Beecham Group Ltd Process for preparing injectable compositions
US4070455A (en) * 1974-02-16 1978-01-24 Beecham Group Limited Process for preparing injectable desensitizing compositions and products thereof in microparticle form
EP0182442B2 (de) 1978-12-22 1996-04-03 Biogen, Inc. Rekombinante DNS-Moleküle und Verfahren zur Herstellung derselben
US4258029A (en) 1979-04-23 1981-03-24 Connaught Laboratories Limited Synthetic adjuvants for stimulation of antigenic responses
US4528029A (en) * 1980-07-21 1985-07-09 Board Of Control Of Michigan Technological University Self-reducing iron oxide agglomerates
US4987237A (en) * 1983-08-26 1991-01-22 Ribi Immunochem Research, Inc. Derivatives of monophosphoryl lipid A
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5244663A (en) * 1987-01-28 1993-09-14 Medibrevex Therapeutic method against allergy
FR2621916B1 (fr) * 1987-10-19 1990-03-09 Bioeurope Derives de la l-tyrosine solubles dans l'eau et procede pour leur preparation
US4912094B1 (en) * 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
GB9106048D0 (en) 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccines
KR950700083A (ko) 1992-03-03 1995-01-16 스즈키 다다시 경구용 백신(oral vaccine)
NZ253137A (en) * 1992-06-25 1996-08-27 Smithkline Beecham Biolog Vaccine comprising antigen and/or antigenic composition, qs21 (quillaja saponaria molina extract) and 3 de-o-acylated monophosphoryl lipid a.
EP0689454B2 (de) * 1993-03-23 2005-02-23 SMITHKLINE BEECHAM BIOLOGICALS s.a. 3-0-deazylierte monophosphoryl lipid a enthaltende impfstoff-zusammensetzungen
DE69426077T3 (de) 1993-05-25 2004-09-02 Wyeth Holdings Corp. Adjuvantien für impfstoffe gegen das respiratorische synzitialvirus
EP0719155A1 (de) 1993-08-27 1996-07-03 Enteric Research Laboratories, Inc. ANTIGENE VON $i(CAMPYLOBACTER JEJUNI), UND VERFAHREN FÜR IHRE HERSTELLUNG UND VERWENDUNG
GB9326253D0 (en) 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
US5997873A (en) * 1994-01-13 1999-12-07 Mount Sinai School Of Medicine Of The City University Of New York Method of preparation of heat shock protein 70-peptide complexes
US5646115A (en) * 1994-10-07 1997-07-08 Heska Corporation Ectoparasite saliva proteins and apparatus to collect such proteins
WO1996025664A1 (en) 1995-02-17 1996-08-22 Immunotherapy, Inc. Immunotherapy screening, prognosis, and treatment methods and compositions
GB9508785D0 (en) * 1995-04-29 1995-06-21 Smithkline Beecham Plc Novel compositions
US5762943A (en) * 1996-05-14 1998-06-09 Ribi Immunochem Research, Inc. Methods of treating type I hypersensitivity using monophosphoryl lipid A
US5973128A (en) * 1996-11-22 1999-10-26 The Hospital For Sick Children Research And Development Lp Glycolipid mimics and methods of use thereof
US6491919B2 (en) 1997-04-01 2002-12-10 Corixa Corporation Aqueous immunologic adjuvant compostions of monophosphoryl lipid A
PL190237B1 (pl) 1997-04-01 2005-11-30 Corixa Corp Kompozycja adiuwantowa, szczepionka, sposób wytwarzania kompozycji adiuwantowej oraz zastosowanie
GB9706957D0 (en) * 1997-04-05 1997-05-21 Smithkline Beecham Plc Formulation
WO1998058956A2 (en) 1997-06-23 1998-12-30 Ludwig Institute For Cancer Research Methods for inducing an immune response involving prime-boost protocols
GB9717953D0 (en) 1997-08-22 1997-10-29 Smithkline Beecham Biolog Vaccine
GB9720585D0 (en) 1997-09-26 1997-11-26 Smithkline Beecham Biolog Vaccine
AU750173B2 (en) 1997-11-10 2002-07-11 Statens Serum Institut Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis
GB9812613D0 (en) 1998-06-11 1998-08-12 Smithkline Beecham Biolog Vaccine
WO1999066043A1 (en) 1998-06-12 1999-12-23 Smithkline Beecham Biologicals S.A. Recombinant production of toxoplasma sag1 antigen
GB9820525D0 (en) * 1998-09-21 1998-11-11 Allergy Therapeutics Ltd Formulation
US6734172B2 (en) 1998-11-18 2004-05-11 Pacific Northwest Research Institute Surface receptor antigen vaccines
ES2173679T3 (es) 1999-01-27 2002-10-16 Idea Ag Inmunizacion/transporte transnasal con vehiculos altamente adaptables.
ATE481108T1 (de) 1999-02-26 2010-10-15 Novartis Vaccines & Diagnostic Verwendung von bioadhaesiven und adjuvantien für die mukosale anwendung von antigenen
GB9909077D0 (en) 1999-04-20 1999-06-16 Smithkline Beecham Biolog Novel compositions
US7285273B1 (en) 1999-04-23 2007-10-23 Pharmexa A/S Method for down-regulating IL5 activity
UA81216C2 (en) 1999-06-01 2007-12-25 Prevention and treatment of amyloid disease
GB9924529D0 (en) 1999-10-15 1999-12-15 Smithkline Beecham Biolog Novel compounds
GB0000891D0 (en) * 2000-01-14 2000-03-08 Allergy Therapeutics Ltd Formulation

Also Published As

Publication number Publication date
DE69824405T2 (de) 2004-10-07
US20050123570A1 (en) 2005-06-09
EP0975364B1 (de) 2004-06-09
AR011707A1 (es) 2000-08-30
US8105605B2 (en) 2012-01-31
GB9706957D0 (en) 1997-05-21
NZ337580A (en) 2001-04-27
KR100549557B1 (ko) 2006-02-08
AU729631B2 (en) 2001-02-08
ZA982851B (en) 1999-10-04
PT975364E (pt) 2004-09-30
KR20010005651A (ko) 2001-01-15
WO1998044947A1 (en) 1998-10-15
CA2285928A1 (en) 1998-10-15
US7718178B2 (en) 2010-05-18
TWI240628B (en) 2005-10-01
JP2001519797A (ja) 2001-10-23
DE69824405D1 (de) 2004-07-15
US20100183659A1 (en) 2010-07-22
ES2218819T3 (es) 2004-11-16
EP0975364A1 (de) 2000-02-02
CA2285928C (en) 2008-07-08
AU7216098A (en) 1998-10-30
JP4331798B2 (ja) 2009-09-16
CO4940482A1 (es) 2000-07-24

Similar Documents

Publication Publication Date Title
ID25533A (id) Formulasi 2-metil-tieno-benzodiazepin
ID24654A (id) Formulasi farmasi omeprazola
PT1006792E (pt) Formulacao agroquimica
MA24473A1 (fr) Formulations
DE69817706D1 (de) UV-Schutzformulierung
DE69838845D1 (de) Zerstäuber
IS5393A (is) Ný froðumyndandi lyfjablanda
ATE285788T1 (de) Aktiviertes protein c formulierungen
DE69823565D1 (de) Zerstäuber
DK0853945T3 (da) Flydende gonadotropinholdige formuleringer
ID28698A (id) Formulasi antiparasit
ID29635A (id) Formulasi mikrokapsul
NO980546D0 (no) Farmasöytiske midler
DE69832562D1 (de) Verbindungsvorrichtung
ID26317A (id) Formulasi pelepasan yang diperpanjang
DK1000079T3 (da) Hidtil ukendt formulering
ID27655A (id) Formulasi mikrokapsul
NO20002555L (no) Skjøt
ID23928A (id) Formulasi mengandung insektisida
DE59808558D1 (de) Bodenelement
ATE268607T1 (de) Allergenformulierung
NO985079D0 (no) Eksplosiv formulering
DE69801367D1 (de) Verbindungsvorrichtung
NO985111D0 (no) Eksplosiv formulering
DE59804391D1 (de) Anschlusseinrichtung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0975364

Country of ref document: EP